Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics
Online ISSN : 1882-8272
Print ISSN : 0388-1601
ISSN-L : 0388-1601
Symposium 10 “Cancer pharmacotherapy in the new era of pharmacogenomics”
S10-3 Proteasome inhibitor, bortezomib, for the treatment of myeloma and lymphoma: reconsiderations on the administrations based on its pharmacokinetic profiles
Kensei TOBINAI
Author information
JOURNAL FREE ACCESS

2008 Volume 39 Issue 4 Pages 101S-102S

Details
Article 1st page
Content from these authors
© 2008 The Japanese Society of Clinical Pharmacology and Therapeutics
Previous article Next article
feedback
Top